Ep23: Conclusion: Reflecting on DTx Limited Edition Series

In this final episode of Digital Therapeutics Edition, Eugene and his journalistic partner, Brian Dolan, reflect on the lessons learned, guest experts, and inspiring stories featured in season one. Brian is a journalist and the founder and lead writer of Exits & Outcomes, and in each episode, he asked the guests a pointed and challenging question about their digital solutions or their outlook on the DTx industry. 
It's been an eventful five months, Brian says -- companies have been bought, merged, and sold, and have raised impressive rounds of funding -- but there are other areas that have seen little progress since the podcast was launched.
There may be a season 2 of Digital Therapeutics Edition, but in the meantime, head over to healthxl.com/dtx to continue the conversation with Eugene and other experts.
What do you think the future of DTx will look like? 

>>Click here to read the transcript

Host Links and Resources:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Follow Eugene's journey of writing his first book: Hard Pill to Swallow


Connect with YourCoach.health: Website | Twitter


Subscribe to Exits & Outcomes


Brian Dolan: Twitter | LinkedIn


HealthXL: Website | Twitter | Join an Event



Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Digital Health Today is made possible by the support of our sponsors. Thank you to:

Bayer G4A

Cedars-Sinai Accelerator

Takeda

Roche